Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Learn how wealth creation through diversified investments can maximize your returns. Build a strong financial future now.
25,092 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This article delivers a practical, numbers-driven view of aurora (AUR) 2026 earnings. Learn the drivers, risks, and w...
As DNOW readies its 2025 earnings narrative, investors should focus on backlog, free cash flow, and guidance. This gu...
Brookfield Asset Management is expanding its AI infrastructure pact with Bloom Energy to $25 billion, signaling a maj...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
When stocks wobble, redirecting payouts to safer assets can cushion the blow. This article explains how dividends rei...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
Is Occidental Petroleum a solid buy, a risky hold, or a limited-scope sell? This guide breaks down the business, the ...
Ecopetrol sits at the crossroads of a volatile energy market and a growing emerging markets economy. This deep dive b...
Investors are eyeing space names as the industry expands. This guide dives into Redwire, asks if it can be a redwire ...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...